clinical trial · NCT07232589
A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)
Merck Sharp & Dohme LLC·phase1·active not recruiting·n = 24
HealthyNemtabrutinibDiltiazem
brief summary
The goal of the study is to learn what happens to levels of nemtabrutinib (MK-1026) in a healthy person's body over time. Researchers will compare what happens to nemtabrutinib in the body when it is given with or without another medicine called diltiazem.
started
Dec 8, 2025
primary completion
May 4, 2026
completion
May 16, 2026
last updated
Apr 14, 2026
official title
A Study to Evaluate the Effect of Multiple Oral Doses of Diltiazem on the Single-Dose Pharmacokinetics of Nemtabrutinib in Healthy Participants.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol